Clinical trial
Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus
NCT00285779 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00285779 |
|---|---|
| Title | Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus |
| Official title | A Double-Blind, Randomized, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Etanercept 50mg SC Twice Weekly in the Treatment of Moderate to Severe Lichen Planus |
| Lead sponsor | Stanford University, Other |
| Collaborators | Wright State University Tufts Medical Center University of Louisville Wake Forest University Health Sciences University of Michigan Emory University University Hospitals Cleveland Medical Center Icahn… |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lichen Planus |
| Intervention type | Drug |
| Interventions | Etanercept, Placebo |
| Enrollment | 27 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Feb 2, 2006 |
| Last update posted | Mar 21, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: